
Experimental Glioblastoma Trial Findings Could Lead to Change in Patient Monitoring and Therapy
Researchers headed by teams at Mass General Brigham Cancer Institute and Harvard Medical School have acquired serial biopsies from two recurrent glioblastoma (rGBM) patients who were involved in an immunotherapy clinical trial, allowing the scientists to …